CDDEP researchers and prominent colleagues propose that a four-pronged global action plan on antimicrobial resistance emerge from the upcoming United Nations General Assembly High-Level Meeting of Heads of State.

In the commentary in The Lancet, CDDEP Director Laxminarayan and co-authors propose a U.N. High-Level Coordinating Mechanism on Antimicrobial Resistance (HLCM) with four core functions: advocacy, monitoring and evaluation, resource mobilization, and the coordination of multisectoral action at the national-level in support of the WHO’s Global Action Plan on Antimicrobial Resistance. The proposed HLCM will be similar in scope and ambition to the highly successful UNAIDS, created in 1996 to address HIV/AIDS. 


CDDEP Director Ramanan Laxminarayan recommends hard targets, funding, and governance to combat AMR, in advance of a United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance on September 21, 2016.

In Science, Laxminarayan and co-authors explain that without specific targets, adequate financing, and an effective One Health governance structure, the resolution expected to emerge from the UNGA session may have little lasting impact. One target would be reducing national per capita antibiotic consumption to the current global median (8.5 defined daily doses per year) in every country, which would reduce global use by 18 percent. 

Use antimicrobials wisely (Nature, Sept 7, 2016)


In a comment in Nature, CDDEP reseachers and other experts in antimicrobial resistance suggest that the United Nations should help reframe global efforts in antimicrobial resistance, to protect the antibiotics the world currently has as well as the global microbiome of susceptible organisms. Investments in antimicrobial research and development have largely focused on developing new drugs and diagnostics—innovations that mainly benefit wealthy nations’ populations and industries. The authors recommend steps  to take in the effort against antimicrobial resistance, including widespread community education, engagement across nations and industries, formation of civil society coalitions, and recognition of the urgency of antibiotic resistance.